Mendel Money Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.05M | Sell |
4,294
-175
| -4% | -$40.8K | 0.44% | 73 |
|
|
2025
Q4 | $925K | Sell |
4,469
-40
| -0.9% | -$7.91K | 0.39% | 78 |
|
|
2025
Q3 | $836K | Sell |
4,509
-16
| -0.4% | -$2.74K | 0.35% | 79 |
|
|
2025
Q2 | $691K | Sell |
4,525
-683
| -13% | -$105K | 0.31% | 78 |
|
|
2025
Q1 | $864K | Sell |
5,208
-1,157
| -18% | -$181K | 0.41% | 67 |
|
|
2024
Q4 | $921K | Sell |
6,365
-345
| -5% | -$53.5K | 0.41% | 64 |
|
|
2024
Q3 | $1.09M | Sell |
6,710
-1,765
| -21% | -$281K | 0.47% | 58 |
|
|
2024
Q2 | $1.24M | Sell |
8,475
-3,338
| -28% | -$496K | 0.58% | 47 |
|
|
2024
Q1 | $1.87M | Buy |
11,813
+759
| +7% | +$121K | 0.86% | 37 |
|
|
2023
Q4 | $1.73M | Sell |
11,054
-1,731
| -14% | -$265K | 0.83% | 38 |
|
|
2023
Q3 | $1.99M | Hold |
12,785
| – | – | 1.07% | 33 |
|
|
2023
Q2 | $2.12M | Sell |
12,785
-7
| -0.1% | -$1.13K | 1.09% | 31 |
|
|
2023
Q1 | $1.98M | Buy |
12,792
+440
| +4% | +$71K | 1.07% | 33 |
|
|
2022
Q4 | $2.18M | Buy |
12,352
+800
| +7% | +$138K | 1.24% | 31 |
|
|
2022
Q3 | $1.89M | Buy |
11,552
+766
| +7% | +$130K | 1.18% | 31 |
|
|
2022
Q2 | $1.92M | Buy |
10,786
+4,698
| +77% | +$837K | 1.14% | 31 |
|
|
2022
Q1 | $1.08M | Buy |
6,088
+4,535
| +292% | +$772K | 0.53% | 43 |
|
|
2021
Q4 | $266K | Sell |
1,553
-423
| -21% | -$69.3K | 0.15% | 65 |
|
|
2021
Q3 | $319K | Buy |
1,976
+68
| +4% | +$11.6K | 0.2% | 61 |
|
|
2021
Q2 | $314K | Sell |
1,908
-10
| -0.5% | -$1.66K | 0.2% | 59 |
|
|
2021
Q1 | $315K | Sell |
1,918
-220
| -10% | -$35.6K | 0.21% | 53 |
|
|
2020
Q4 | $336K | Buy |
2,138
+85
| +4% | +$12.5K | 0.24% | 50 |
|
|
2020
Q3 | $306K | Sell |
2,053
-15
| -0.7% | -$2.22K | 0.24% | 49 |
|
|
2020
Q2 | $291K | Buy |
+2,068
| New | +$301K | 0.26% | 48 |
|
|
2019
Q4 | $357K | Sell |
2,448
-597
| -20% | -$81K | 0.31% | 42 |
|
|
2019
Q3 | $394K | Sell |
3,045
-1,195
| -28% | -$157K | 0.36% | 40 |
|
|
2019
Q2 | $591K | Buy |
+4,240
| New | +$587K | 0.57% | 34 |
|
|
2018
Q3 | $562K | Buy |
+4,071
| New | +$541K | 0.55% | 33 |
|
|
2017
Q4 | $569K | Buy |
+4,071
| New | +$567K | 0.55% | 34 |
|
|
2015
Q2 | – | Sell |
-2,013
| Closed | -$202K | – | 54 |
|
|
2015
Q1 | $202K | Hold |
2,013
| – | – | 0.19% | 49 |
|
|
2014
Q4 | $210K | Hold |
2,013
| – | – | 0.2% | 49 |
|
|
2014
Q3 | $215K | Buy |
+2,013
| New | +$209K | 0.21% | 48 |
|
Other funds holding JNJ
VCM
VPM
Mendel Money Management's JNJ Position: Q1 2026 in Review
Mendel Money Management reduced its Johnson & Johnson (JNJ) stake by 3.9% in Q1 2026, selling an estimated $40.8K and leaving 4,294 shares worth $1.05M. The position accounts for 0.44% of the portfolio, ranked #73.
Mendel Money Management first reported a position in JNJ in Q3 2014 and has held it in 32 quarters since. The position peaked at $2.18M in Q4 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Mendel Money Management held 4,294 shares of Johnson & Johnson worth $1.05M as of Q1 2026.
- Mendel Money Management sold 175 Johnson & Johnson shares in Q1 2026, an estimated $40.8K.
- Johnson & Johnson made up 0.44% of Mendel Money Management's portfolio in Q1 2026, its #73 holding.
- Mendel Money Management first reported a position in Johnson & Johnson in Q3 2014 and has held it in 32 quarters since.
- Mendel Money Management's Johnson & Johnson position peaked at $2.18M in Q4 2022.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Mendel Money Management's 13F filing for Q1 2026, filed 4 May 2026.